HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gentisic acid protects against diabetic nephropathy in Nicotinamide-Streptozotocin administered male mice by attenuating oxidative stress and inflammation: The role of miR-200a/Keap1/Nrf2 pathway, renin-angiotensin system (RAS) and NF-кB.

Abstract
Oxidative stress and inflammation play a pivotal role in the pathogenesis of diabetic nephropathy (DN). Local renin-angiotensin systems (RAS) contribute to the pathogenesis and progression of DN by exacerbating oxidative stress and inflammation.Gentisic acid (GA), a phenolic compound and also a metabolite of aspirin, is reported to possess antioxidant and anti-inflammatory properties. However, the protective effects of GA against DN remain to be elucidated. Nicotinamide (120 mg/kg) and streptozotocin (65 mg/kg) were used to induce diabetes in male mice. Oral administration of GA once daily for 2 weeks (100 mg/kg) ameliorated diabetes-induced renal injury by reducing plasma creatinine, urea, blood urea nitrogen, and urinary albuminuria levels. Diabetic mice showed a significant increase in total oxidant status and malondialdehyde, along with decreased catalase, superoxide dismutase, and glutathione peroxidase in the kidney tissue, which was ameliorated in the GA-treated mice. Histopathological analysis showed that GA treatment reduced diabetes-induced renal injury. Furthermore, GA treatment was associated with the downregulation of miR-125b, nuclear factor kappa beta (NF-кB), tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), and upregulation of interleukin-10 (IL-10), miR-200a, and nuclear factor erythroid 2-related factor 2 (Nrf2) in the renal tissue. GA treatment also downregulated angiotensin-converting enzyme 1 (ACE1), angiotensin II receptor 1 (AT1R), and NADPH oxidase 2 (NOX 2) and upregulated angiotensin-converting enzyme 2 (ACE2). In conclusion, the ameliorative effects of GA against DN may be attributed to its powerful antioxidant and anti-inflammatory properties through the downregulation of NF-кB, upregulation of Nrf2, and modulation of RAS in renal tissue.
AuthorsReza Noei Razliqi, Akram Ahangarpour, Seyyed Ali Mard, Layasadat Khorsandi
JournalChemico-biological interactions (Chem Biol Interact) Vol. 380 Pg. 110507 (Aug 01 2023) ISSN: 1872-7786 [Electronic] Ireland
PMID37120126 (Publication Type: Journal Article)
CopyrightCopyright © 2023. Published by Elsevier B.V.
Chemical References
  • NF-kappa B
  • Streptozocin
  • NF-E2-Related Factor 2
  • 2,5-dihydroxybenzoic acid
  • Antioxidants
  • Niacinamide
  • Kelch-Like ECH-Associated Protein 1
  • Anti-Inflammatory Agents
  • MicroRNAs
  • Angiotensins
  • Keap1 protein, mouse
Topics
  • Mice
  • Male
  • Animals
  • Diabetic Nephropathies (pathology)
  • NF-kappa B (metabolism)
  • Streptozocin (toxicity)
  • Renin-Angiotensin System
  • NF-E2-Related Factor 2 (metabolism)
  • Antioxidants (metabolism)
  • Niacinamide (pharmacology, therapeutic use)
  • Diabetes Mellitus, Experimental (complications, drug therapy, metabolism)
  • Kelch-Like ECH-Associated Protein 1 (metabolism)
  • Kidney
  • Oxidative Stress
  • Inflammation (metabolism)
  • Anti-Inflammatory Agents (pharmacology, therapeutic use, metabolism)
  • MicroRNAs (metabolism)
  • Angiotensins (metabolism, pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: